Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety.

[1]  J. Beijnen,et al.  Model‐Based Evaluation of Similarity in Pharmacokinetics of Two Formulations of the Blood‐Derived Plasma Product C1 Esterase Inhibitor , 2012, Journal of clinical pharmacology.

[2]  J. Stockman.  Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema , 2012 .

[3]  J. Bernstein,et al.  Successful C1 inhibitor short-term prophylaxis during redo mitral valve replacement in a patient with hereditary angioedema , 2010, Journal of cardiothoracic surgery.

[4]  J. Bernstein,et al.  Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. , 2010, The New England journal of medicine.

[5]  J. Bernstein,et al.  Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[6]  P. Keith,et al.  2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[7]  J. Hayashi,et al.  Supplementation of C1-esterase inhibitor concentrates for a patient suffering from hereditary angioedema undergoing complex open-heart surgery. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[8]  Gerhard Nahler,et al.  Committee for Proprietary Medicinal Products (CPMP) , 2009 .

[9]  B. Penninx,et al.  A Randomized Controlled Trial of a Tailored Primary Care Program to Reverse Excessive Alcohol Consumption , 2012, The Journal of the American Board of Family Medicine.

[10]  M. Frank.  8. Hereditary angioedema. , 2008, The Journal of allergy and clinical immunology.

[11]  William H. Yang,et al.  Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[12]  J. Bernstein.  Hereditary angioedema: a current state-of-the-art review, VIII: current status of emerging therapies. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[13]  A. Sheffer,et al.  Hereditary angioedema: a current state-of-the-art review, V: attenuated androgens for the treatment of hereditary angioedema. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[14]  H. Schuitemaker,et al.  Viral safety of C1-inhibitor NF. , 2007, Biologicals : journal of the International Association of Biological Standardization.

[15]  M. Levi,et al.  Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. , 2006, The Journal of allergy and clinical immunology.

[16]  W. Kreuz,et al.  Individual Replacement Therapy (IRT) with a Pasteurized C1-Inhibitor Concentrate Compared to Prophylaxis with Danazol in Patients with Hereditary Angioedema (HAE) - A Prospective Study , 2006 .

[17]  K. Bork,et al.  Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema , 2005, Transfusion.

[18]  M. Burke,et al.  Angio-oedema in dentistry: management of two cases using C1 esterase inhibitor. , 2005, Dental update.

[19]  M. Gompels,et al.  C1 inhibitor deficiency: consensus document , 2005, Clinical and experimental immunology.

[20]  K. Kragballe,et al.  Hereditary Angioedema. , 2018, The New England journal of medicine.

[21]  T. Klingebiel,et al.  Individual Replacement Therapy (IRT) with a Pasteurized C1-Inhibitor Concentrate Compared to Prophylaxis with Danazol in Patients with Hereditary Angioedema (HAE) - a Prospective Study. , 2004 .

[22]  William H. Yang,et al.  Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema. , 2004, The Journal of allergy and clinical immunology.

[23]  J. Church.  Oxandrolone treatment of childhood hereditary angioedema. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[24]  J. Lindner,et al.  Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert® P) in hereditary angioedema: a review , 2003 .

[25]  K. Bork,et al.  Sudden upper airway obstruction in patients with hereditary angioedema. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[26]  K. Bork,et al.  Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. , 2003, Archives of internal medicine.

[27]  P. Brown,et al.  Factor VIII and transmissible spongiform encephalopathy: the case for safety , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[28]  M. Cicardi,et al.  Mechanisms of C1-inhibitor deficiency. , 2002, Immunobiology.

[29]  K. Bork,et al.  Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. , 2001, Archives of internal medicine.

[30]  S. Mohri,et al.  Scrapie removal using Planova virus removal filters. , 2001, Biologicals : journal of the International Association of Biological Standardization.

[31]  B. Griffin,et al.  Studies on the Removal of Abnormal Prion Protein by Processes Used in the Manufacture of Human Plasma Products , 2000, Vox Sanguinis.

[32]  J. Alvarez.  Successful use of C1 esterase inhibitor protein in a patient with hereditary angioneurotic edema requiring coronary artery bypass surgery. , 2000, The Journal of thoracic and cardiovascular surgery.

[33]  F. Rosen,et al.  A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema , 1998, Transfusion.

[34]  F. Rosen,et al.  Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. , 1996, The New England journal of medicine.

[35]  W. Kreuz,et al.  Hepatitis C and pasteurized C1‐inhibitor concentrate , 1996, Transfusion.

[36]  P. Mannucci,et al.  Reduction in transmission of hepatitis C after the introduction of a heat‐treatment step in the production of C1‐inhibitor concentrate , 1995, Transfusion.

[37]  P. Spaeth,et al.  Hereditary angioedema: uncomplicated maxillofacial surgery using short-term C1 inhibitor replacement therapy. , 1993, International archives of allergy and immunology.

[38]  K. Bork,et al.  Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency. , 1989, The Journal of allergy and clinical immunology.

[39]  A. Sheffer,et al.  Hereditary angioedema: a decade of management with stanozolol. , 1987, The Journal of allergy and clinical immunology.

[40]  Y. Myreng,et al.  [Treatment of hereditary angioedema with danazol]. , 1983, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[41]  A. Sheffer,et al.  Clinical and biochemical effects of stanozolol therapy for hereditary angioedema. , 1981, The Journal of allergy and clinical immunology.

[42]  M. Cicardi,et al.  Treatment of acute attacks of hereditary angioedema with C1-inhibitor concentrate. , 1980, Annals of allergy.

[43]  J. Gelfand,et al.  Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. , 1980, The New England journal of medicine.

[44]  R. L. Green,et al.  Prophylaxis of attacks of hereditary angioedema. , 1979, The American journal of medicine.

[45]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.

[46]  H. Brummelhuis,et al.  Contributions to the Optimal Use of Human Blood , 1976 .

[47]  H. Brummelhuis,et al.  Contributions to the Optimal Use of Human Blood , 1974, Vox sanguinis.

[48]  Vogelaar Ef,et al.  Contributions to the Optimal Use of Human Blood , 1974, Vox sanguinis.

[49]  A. Sheffer,et al.  Tranexamic acid therapy in hereditary angioneurotic edema. , 1972, The New England journal of medicine.

[50]  D. Alling,et al.  Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study. , 1972, The New England journal of medicine.